medindexer
Industry News · Live

What's moving the medical supply market.

Curated from medtech publications. Product launches, FDA clearances, M&A, technology shifts — rewritten as short briefs, linked back to the source. Filter by theme below.

Live
Stories
0
Sources
0
Updated
0hours ago
Filter:AllTechnologyNew productsRegulationMarket
Feed · market
§001MarketApril 24, 2026

Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy

Telehealth clinic Hone Health partnered with imaging vendor BodySpec to offer DEXA body composition scans to GLP-1 patients. The collaboration aims to help providers differentiate fat loss from muscle loss during treatment, enabling more detailed assessment of drug efficacy beyond weight metrics alone. The partnership represents a vendor strategy move to integrate diagnostic imaging into remote weight-management workflows.

Source · MedCity NewsRead brief
§002MarketApril 24, 2026

Courier Health scores $50M to scale CRM technology

Courier Health, a health tech platform serving life sciences manufacturers, closed a $50 million Series B funding round led by Oak HC/FT, with participation from Norwest and Work-Bench. The New York-based company provides CRM technology to help manufacturers manage customer relationships and sales operations.

Source · Mobi Health NewsRead brief
§003MarketApril 24, 2026

Top Silicon Valley VCs Are Backing a New Health Tech Residency Program

The AI Health Fund launched Treehub, a residency program for early-stage healthcare AI startups, backed by prominent venture investors including Tim Draper and Anne Wojcicki. The program targets companies at pre-formation stages, signaling continued capital flow into the health tech vendor ecosystem.

Source · MedCity NewsRead brief
§004MarketApril 23, 2026

Boston Scientific reports steady Q1 2026 performance yet tempers FY26 outlook

Boston Scientific reported 11.2% year-over-year growth in Q1 2026 but reduced its full-year 2026 revenue guidance, trimming the top-end growth outlook by 2 percentage points. The adjustment signals caution amid what the company characterized as steady near-term performance across its device portfolio.

Source · Medical Device NetworkRead brief
§005MarketApril 22, 2026

AcuityMD raises $80m for AI augmentation to medtech sales platform

AcuityMD secured $80 million in funding to expand its AI-powered sales platform serving medical device companies. The platform is designed to streamline commercial execution and sales operations for medtech vendors. The fresh capital will support integration of advanced AI capabilities into the existing system.

Source · Medical Device NetworkRead brief
§006MarketApril 21, 2026

CPC Biotech debuts unified bioprocess fluid portfolio

CPC Biotech has launched as a unified brand combining CPC's biopharma connectors with PSG Biotech's pumps, flow meters, and sensors into an integrated bioprocess fluid management portfolio. The company will debut publicly at INTERPHEX 2026 in April at the Javits Center in New York City. The consolidation brings together critical fluid handling components and expertise for biopharmaceutical manufacturing.

Source · Medical Design & OutsourcingRead brief
§007MarketApril 20, 2026

Henry Schein discloses exec pay for longtime CEO Stan Bergman’s final year

Henry Schein disclosed executive compensation for 2025, reporting pay increases for three of five top executives in what marks longtime CEO Stan Bergman's final year leading the Melville, New York-based medical products distributor. The company also raised median employee compensation year-over-year. Bergman has led Henry Schein, ranked among the world's largest medical device suppliers, for an extended tenure.

Source · Medical Design & OutsourcingRead brief
§008MarketApril 20, 2026

Eli Lilly Makes Another In Vivo Genetic Medicines Move With $3.2B Kelonia Acquisition

Eli Lilly acquired Kelonia Therapeutics for $3.2 billion to add an in vivo cell therapy program targeting multiple myeloma. The deal marks Lilly's third genetic medicines acquisition in as many years, following purchases of Verve and Orna Therapeutics, as the pharmaceutical giant diversifies its approach to in vivo genetic therapy across multiple platforms and disease targets.

Source · MedCity NewsRead brief
§009MarketApril 15, 2026

Abbott’s device leader pay climbs again with double-digit sales growth

Abbott's EVP and Medical Devices Group President Lisa Earnhardt received a compensation package increase exceeding 20% in 2025, reflecting double-digit sales growth in the division. Abbott ranked eighth globally among medical device companies by revenue in the latest Medtech Big 100 rankings. The pay rise underscores strong financial performance in the device segment amid broader market momentum.

Source · Medical Design & OutsourcingRead brief
§010MarketApril 13, 2026

Switchback Medical is expanding into Costa Rica

Switchback Medical, a medical device contract development and manufacturing organization, has signed a lease for an 18,000-square-foot facility in Costa Rica's Coyol Free Trade Zone. The expansion marks the company's first international manufacturing footprint outside its Brooklyn Park, Minnesota headquarters, signaling a strategic shift in production capacity and supply-chain positioning for the CDMO sector.

Source · Medical Design & OutsourcingRead brief
§011MarketApril 10, 2026

CDMO Arterex upgrades manufacturing facility near Boston

Arterex, a contract device manufacturer, is expanding its Mansfield, Massachusetts facility by 15,000 square feet and installing a new steam sterilizer to boost operational capacity by nearly 50%. The upgrade aims to improve inventory control and logistics efficiency for its contract manufacturing customers.

Source · Medical Design & OutsourcingRead brief
§012MarketApril 10, 2026

Medtech CDMO Integer discloses executive pay after new CEO steps in

Integer Holdings Corp., a contract manufacturer and CDMO for medical devices, disclosed executive compensation packages following a new CEO appointment in an SEC filing. The company also reported a significant increase in median employee pay. Integer ranks among the top 60 medical device companies globally.

Source · Medical Design & OutsourcingRead brief
§013MarketApril 1, 2026

Whoop raises $575M series G, Abbott comes on board amid hiring spree

Whoop, a fitness wearable maker, raised $575 million in Series G funding with Abbott as a new investor. The round comes as Whoop expands hiring and positions itself for growth in the consumer health monitoring space. Abbott's participation signals potential distribution or integration opportunities between the companies.

Source · Fierce HealthcareRead brief
§014MarketDecember 17, 2025

Medline makes Nasdaq debut, raising $6.26B in year's largest IPO

Medline Industries completed its Nasdaq initial public offering, raising $6.26 billion in the largest IPO of 2024. The medical device and supply distributor, previously held by private equity, transitions to public ownership. The offering marks a significant milestone for one of the U.S.'s largest medical equipment and consumables vendors and signals investor appetite for established medical-supply businesses.

Source · Fierce HealthcareRead brief
§015MarketNovember 20, 2025

GE HealthCare to acquire imaging software provider Intelerad for $2.3B

GE HealthCare announced a $2.3 billion acquisition of Intelerad, a cloud-based imaging software provider serving radiology, cardiology, and clinical trial workflows. The deal expands GE HealthCare's outpatient imaging portfolio and complements its existing in-hospital imaging infrastructure. Intelerad's platform serves independent practices and healthcare networks with DICOM viewing, management, and AI-enabled analysis tools.

Source · Fierce HealthcareRead brief
§016MarketNovember 20, 2025

Abbott dives into cancer diagnostics with $23B buyout of Exact Sciences

Abbott announced a $23 billion acquisition of Exact Sciences, the developer of Cologuard and blood-based cancer screening tests. The deal marks the largest diagnostics acquisition to date and significantly expands Abbott's oncology diagnostic portfolio, combining Exact Sciences' colorectal and multi-cancer detection platforms with Abbott's existing diagnostic infrastructure and distribution capabilities.

Source · Fierce HealthcareRead brief
§017MarketAugust 22, 2025

Tempus claims AI pathology developer Paige in $81M deal

Tempus acquired AI pathology developer Paige for $81 million, gaining access to a dataset of nearly 7 million digitized pathology slides and associated clinical data from Memorial Sloan Kettering Cancer Center. The acquisition adds Paige's machine-learning capabilities in digital pathology to Tempus's oncology-focused platform.

Source · Fierce HealthcareRead brief
§018MarketAugust 15, 2025

Philips to invest $150M in US manufacturing base, including ultrasound site expansion

Philips announced a $150 million investment in its U.S. manufacturing footprint, including expansion of a Pennsylvania facility dedicated to hospital ultrasound equipment production. The move reflects the company's strategy to strengthen domestic manufacturing capacity for imaging hardware.

Source · Fierce HealthcareRead brief
§019MarketAugust 4, 2025

Ultromics nets $55M to boost its AI ultrasound software for detecting hidden heart failure

Ultromics secured $55 million in venture funding to scale its AI-driven ultrasound software platform for detecting occult heart failure. The funding will support commercial expansion of the company's diagnostic tools, which use machine learning to identify cardiac abnormalities from echocardiography images that may be missed by conventional analysis.

Source · Fierce HealthcareRead brief